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Abstract Receptor-mediated production of inositol 1,4,5-tris-
phosphate (InsP3) initiates Ca2
+ release and is responsible for
cytosolic Ca2+ oscillations. InsP3 oscillations have also been
observed in some cells. One of the enzymes controlling InsP3
catabolism, the InsP3 3-kinase, is stimulated by Ca2
+; this reg-
ulation is presumably part of the reason for InsP3 oscillations
that have been observed in some cells. Here, we investigate the
possible role of Ca2+-activated InsP3 catabolism on the charac-
teristics of the InsP3-induced Ca2
+ oscillations. Numerical sim-
ulations show that if it is assumed that the Ca2+-independent
InsP3 catabolism is predominant, Ca2
+ oscillations remain qual-
itatively unchanged although the relative amplitude of the oscil-
lations in InsP3 concentrations becomes minimal. We tested this
prediction in hepatocytes by masking the Ca2+-dependent InsP3
catabolism by 3-kinase through the injection of massive amounts
of InsP3 5-phosphatase, which is not stimulated by Ca2
+. We
¢nd that in such injected hepatocytes, Ca2+ oscillations gener-
ated by modest agonist levels are suppressed, presumably be-
cause of the decreased dose in InsP3, but that at higher doses of
agonist, oscillations reappear, with characteristics similar to
those of untreated cells at low agonist doses. Altogether, these
results suggest that oscillations in InsP3 concentration due to
Ca2+-stimulated InsP3 catabolism do not play a major role for
the oscillations in Ca2+ concentration.
0 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Inositol 1,4,5-trisphosphate (InsP3) is a widespread second
messenger inducing Ca2þ release from endoplasmic reticulum
(ER) stores. In the vast majority of cell types, the resulting
rise of Ca2þ in the cytosol takes the form of repetitive Ca2þ
oscillations, whose period ranges from seconds to minutes
[1,2]. One of the most accepted explanations for Ca2þ oscil-
lations rests on the biphasic regulation of the InsP3 receptor
(InsP3R), which can be activated by low concentrations of
Ca2þ and inactivated by higher concentrations of this messen-
ger. Within the framework of this explanation, Ca2þ oscilla-
tions can be generated in the presence of a constant level of
InsP3, with the level of InsP3 controlling the presence and the
frequency of Ca2þ oscillations [3,4].
In some cell types, it has recently become possible to detect
changes in InsP3 levels in single cells [5^7]. The observation
that in these cases Ca2þ and InsP3 oscillate in synchrony
suggests that feedbacks at the level of InsP3 synthesis or/and
catabolism might play a role in the regulation of Ca2þ dy-
namics. Pathways of InsP3 synthesis and degradation have
been well characterized [8] and are schematized in Fig. 1.
Upon binding to its speci¢c membrane receptor, the external
stimulus (A) triggers the activation of receptor-associated G-
proteins. This in turn stimulates a phospholipase C (PLC)
which catalyzes the hydrolysis of membrane-bound phospha-
tidyl inositol 4,5-bisphosphate (PIP2) to form InsP3 and diac-
ylglycerol (DAG). Already at this level, InsP3 oscillations
could arise either through regulation of protein kinase C
(PKC), a Ca2þ- and DAG-dependent kinase that could exert
a negative feedback on the receptor^G-protein complex [9,10],
or through a Ca2þ stimulation of PLC activity [10^12] (the
latter e¡ect does not seem to occur in hepatocytes [13,14]).
These two mechanisms could generate InsP3 oscillations due
to negative or positive regulation of InsP3 synthesis ; Ca2þ
oscillations would thus be driven by InsP3 oscillations.
However, if Ca2þ regulates InsP3 catabolism, InsP3 oscilla-
tions could also be a consequence, rather than a cause, i.e.
they could simply follow Ca2þ oscillations, themselves pro-
duced by the above-mentioned biphasic regulation of the
InsP3R. InsP3 can be transformed either by InsP3 5-phos-
phatase-mediated dephosphorylation to yield inositol 1,4-
bisphosphate, or by InsP3 3-kinase-mediated phosphorylation
to yield inositol 1,3,4,5-tetrakisphosphate (InsP4) [15]. Note
that InsP4 is also a substrate for 5-phosphatase and thus
acts as a competitive inhibitor of InsP3 dephosphorylation.
The binding of Ca2þ/calmodulin (CaM) to 3-kinase enhances
its activity at variable extents: the A isoform of the enzyme is
stimulated 2- to 3-fold by Ca2þ/CaM, whereas the B isoform
is stimulated up to 10-fold [16,17].
Mathematical modelling [10,18,19] has con¢rmed the intui-
tive prediction that this well-characterized Ca2þ stimulation of
InsP3 catabolism can generate InsP3 oscillations. Basically,
one could conceive two e¡ects of these catabolism-induced
InsP3 oscillations. First, an active role of these oscillations
in the pacemaker mechanism of Ca2þ oscillations was sug-
gested by studies performed in hepatocytes [20] and smooth
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muscle cells [21]. It was there shown that the Ca2þ signal
following uncaging of poorly-metabolized InsP3 analogs de-
cayed more slowly than the signal following InsP3 uncaging.
The interpretation of Fink et al. [21] was that InsP3 degrada-
tion was a prerequisite for Ca2þ recovery. The control of
InsP3 removal by a Ca2þ-stimulated 3-kinase would provide
an ideal mechanism for this. Second, even if InsP3 oscillations
are not strictly required for Ca2þ oscillations, one could argue
that the enhanced degradation of InsP3 following a Ca2þ
spike (due to Ca2þ-enhanced activity of the InsP3 3-kinase)
plays a role in determining the relatively low frequency of
Ca2þ oscillations, which cannot be explained on the basis of
the kinetic properties of the InsP3R [22]. In this view, each
Ca2þ spike would provoke a decrease in InsP3 so that the level
of this messenger becomes too low to allow Ca2þ release
through the InsP3R. Consequently, the long period would
correspond to the time necessary to rebuild the level of InsP3
necessary to activate Ca2þ release through the receptor.
In the present study, we investigate both theoretically and
experimentally the possible role of the Ca2þ-controlled catab-
olism of InsP3 in the triggering and characteristics of Ca2þ
oscillations. We ¢rst use a previously developed theoretical
model [18,22] to analyze the e¡ect of masking the Ca2þ-sensi-
tive pathway of InsP3 catabolism by a Ca2þ-insensitive one.
The model predicts that Ca2þ oscillations remain qualitatively
unchanged, although InsP3 oscillations practically disappear.
This prediction is then corroborated by experiments of InsP3
5-phosphatase injection in hepatocytes.
2. Materials and methods
2.1. Preparation of hepatocytes
Isolated rat hepatocytes were prepared from fed female Wistar rats
by limited collagenase (from Boehringer) digestion of rat liver, as
previously described [23]. Under these conditions, about 20% of the
cells recovered were associated by two (doublet) or three (triplet), and
were ascertained not to be non-speci¢c aggregates of non-connected
cells by conventional light screening for dilated bile canaliculi, indica-
tors of maintained functional polarity. After isolation, rat hepatocytes
were maintained (5U105 cells/ml) at 4‡C in Williams’ medium E
(Gibco) supplemented with 10% fetal calf serum, penicillin (100 000
units/ml) and streptomycin (100 Wg/ml). Cell viability, assessed by
trypan blue exclusion, remained greater than 96% for 4^5 h.
2.2. Measurement of intracellular Ca2+ in individual cells
2.2.1. Loading of hepatocytes with fura2. Hepatocytes were loaded
with fura2 (Molecular Probes Inc.) by injection (see below). Small
aliquots of the suspended hepatocytes (5U105 cells) were diluted in
2 ml of Williams’ medium E modi¢ed as described above, then plated
onto dish glass coverslips coated with collagen I, and incubated for 60
min at 37‡C under an atmosphere containing 5% CO2. After cell
plating, the coverslips were then washed twice with a saline solution
(20 mM HEPES, 116 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8
mM MgCl2, 0.96 mM NaH2PO4, 5 mM NaHCO3, and 1 g/l glucose,
pH 7.4). Dish coverslips were put onto a thermostated holder (36‡C)
on the stage of a Zeiss Axiovert 35 microscope set up for epi£uor-
escence microscopy.
2.2.2. Microinjection. Microinjection was performed using an Ep-
pendorf microinjector (5242), as described previously [24]. Micropi-
pettes with an internal tip diameter of 0.5 Wm (Femtotips, Eppendorf)
were ¢lled with test agents and 5 mM fura2 in a bu¡er solution
containing 100 mM KCl, 20 mM NaCl and 10 mM HEPES adjusted
to pH 7.1. After microinjection, cells were allowed to recover for at
least 10 min. The success of microinjection was assessed by monitor-
ing the morphology of cells and their ability to retain injected fura2
and to display a low [Ca2þ]i. Cells were microinjected either with
inactivated InsP3 5-phosphatase or with InsP3 5-phosphatase (activ-
ity: 120 nmol/min/ml in the pipette). Puri¢cation and determination
of activity of the recombinant type I InsP3 5-phosphatase (19 Wmol/
min/ml in this study) were performed as described previously [25].
InsP3 5-phosphatase was inactivated at 90‡C for 20 min.
Ca2þ imaging was described previously [24].
3. Theoretical prediction as to the role of the Ca2+-stimulated
InsP3 catabolism
The model for Ca2þ oscillations [18,22] relies on the bipha-
sic regulation of the InsP3R by Ca2þ, with InsP3 synthesized
at a constant rate (proportional to the level of stimulation)
and degraded by both 3-kinase and 5-phosphatase. The 3-ki-
nase is stimulated by Ca2þ, and its product, InsP4, competes
with InsP3 for 5-phosphatase (Fig. 1). When the concentration
of agonist (and thus of InsP3) increases, cells typically display:
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Fig. 1. Schematic representation of the intracellular Ca2þ dynamics and of the InsP3 signalling pathway in a doublet of connected hepatocytes.
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(1) low constant levels of Ca2þ, (2) sustained Ca2þ oscilla-
tions, the frequency of which increases with the agonist con-
centration, and (3) high sustained levels of Ca2þ [1^4].
Numerical simulations also show that the level of InsP3
oscillates in phase with Ca2þ (Fig. 2A). As these oscillations
rely on the Ca2þ stimulation of InsP3 catabolism by 3-kinase,
it can be expected that their amplitude would be much re-
duced if the relative importance of the other degradation
pathway was increased. Thus, we simulated the e¡ect of 5-
phosphatase injection and assumed that the concentration of
this enzyme is increased by a factor of 25. If all the other
parameters of the model are kept constant, oscillations are
abolished and a low constant level of Ca2þ is predicted, con-
sistent with the observed reduction in the level of InsP3 (Fig.
2B). If the external stimulation is then increased, Ca2þ oscil-
lations are recovered, but now occur in the presence of a
nearly constant level of InsP3 (Fig. 2C). In this case, the
average activity of the phosphatase exceeds that of the kinase
by a factor of 30, while both activities were roughly the same
in the normal situation corresponding to Fig. 2A.
Interestingly, these results predict that the characteristics of
the repetitive Ca2þ spikes (shape, amplitude and order of
magnitude of the period) remain similar to those obtained
in response to submaximal stimulation of a cell that was
not supposed to be injected with the enzyme. Thus, the model
suggests that InsP3 oscillations driven by Ca2þ-activated InsP3
degradation are not essential for InsP3-induced Ca2þ oscilla-
tions. Detailed examination of the behavior of the model
shows that this lack of e¡ect is due to (1) receptor inactivation
Fig. 2. Theoretical prediction as to the possible role of the Ca2þ-
stimulated InsP3 catabolism. A: Oscillations in Ca2þ (solid line) and
InsP3 (dashed line) in a cell stimulated with a submaximal dose of
agonist. B: The amount of 5-phosphatase in the simulated cell has
been multiplied by 25 as compared to its value in A. C: Ca2þ oscil-
lations can reappear if the cell is stimulated with a high dose of ag-
onist. Curves have been obtained by numerical simulations of the
model [20] with: Kact = 0.5 WM, na = 3, Kinh = 0.17 WM, ni = 4,
k3 =0.5 s31, k1 = 2.57 s31, b=0.0007 s31, KIP = 1 WM, VMP =6 WM
s31, KP = 0.35 WM, K=0.1, Catot = 80 WM, VPLC = 4 WM s31, Vk =
5 WM s31, Kk = 1 WM, Kd = 0.3 WM, nd = 2. For A: Q=0.12, Vp1 =
5 WM s31, Vp2 = 0.2 WM s31, for B: Q=0.12, Vp1 = 125 WM s31,
Vp2 = 5 WM s31, and for C: Q=1, Vp1 = 125 WM s31, Vp2 = 5 WM
s31. These parameters only aim at qualitatively representing the sit-
uation encountered in hepatocytes, as most parameters are experi-
mentally unknown. Scales are in s and WM.
A
B
Fig. 3. E¡ect of 5-phosphatase on InsP3-dependent agonist-induced
[Ca2þ]i oscillations. One cell of the doublet (lower trace in each
panel) was microinjected with fura2 and either with inactive (A) or
active InsP3 5-phosphatase (B). Then, hepatocyte doublets were
challenged with noradrenaline (Nor, 0.1 WM or 10 WM) for the time
shown by the horizontal bar. Results are representative of those ob-
tained using four (A) and ¢ve (B) doublets. For technical conven-
ience, tracings were interrupted (the gap represents 3 min).
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being much faster than InsP3 removal, and (2) minimal levels
of InsP3 during the course of oscillations being still above the
threshold required for an oscillatory behavior.
4. Experimental results: e¡ect of injecting InsP3 5-phosphatase
into one cell of a hepatocyte doublet
In liver, hepatocytes are tightly coupled by gap junctions
[26]. Ca2þ increases induced by agonists activating the InsP3
cascade, such as vasopressin or noradrenaline, are highly co-
ordinated within multiplets when gap junctions are functional
(e.g. Fig. 3A and see [27] for review). Previous work suggests
that calcium spikes are coordinated by the di¡usion of small
amounts of InsP3 between cells that slightly di¡er in their
sensitivity to the hormonal stimulus [28] (but see also [29]).
The fact that these coupled cells show very similar Ca2þ
oscillations provides an ideal tool to evaluate the role of InsP3
metabolism in the regulation of Ca2þ dynamics (see Fig. 1 for
a schematic representation of the experiments). Indeed, injec-
tion of an enzyme that acts speci¢cally on InsP3 catabolism in
the injected cell but cannot di¡use through gap junctions
makes it possible to observe the e¡ect of InsP3 metabolism
on Ca2þ oscillations, while the non-injected cell provides a
natural control for unperturbed Ca2þ oscillations. Moreover,
3-kinase B has been isolated from rat hepatocytes [30] and
shown to be stimulated by Ca2þ [31], while the activity of
InsP3 5-phosphatase has been shown to be una¡ected by
changes in [Ca2þ] in this cell type [32]. Thus, we have injected
type I InsP3 5-phosphatase in only one cell of hepatocyte
doublets. This isoform is the most widespread of InsP3 5-
phosphatases and it is not stimulated by Ca2þ [33].
Together with InsP3 5-phosphatase, fura2 was microin-
jected; di¡usion of this dye via gap junctions revealed that
the two cells were indeed coupled. As shown in Fig. 3A, con-
trol injection in one cell of InsP3 5-phosphatase that had been
previously inactivated did not result in any di¡erence between
the two cells as regards noradrenaline-induced Ca2þ oscilla-
tions. The two cells showed similar Ca2þ responses both at
low (0.1 WM) and maximal (10 WM) noradrenaline concentra-
tion. In contrast, Ca2þ signals in the two cells were di¡erent
when active InsP3 5-phosphatase had been injected into one
cell of the doublet, whatever the concentration of the agonist
(Fig. 3B), consistent with the reduction of the InsP3 concen-
tration in the injected cell anticipated by the model (Fig. 2B).
In contrast, at supra-maximal concentrations of noradren-
aline (10 WM), the non-injected cell shows a high sustained
level of Ca2þ, re£ecting a very high level of InsP3, but the
injected cell displays low-frequency Ca2þ oscillations, typical
of an intermediate level of InsP3 (Fig. 3B, right panel). Thus,
as predicted by the model (Fig. 2C), a hepatocyte that has
been made silent by injection of 5-phosphatase can become
responsive again by increasing the concentration of the ago-
nist. The critical observation is that oscillatory Ca2þ signals
can be observed at high enough agonist concentrations, de-
spite the massive Ca2þ-independent InsP3 catabolism induced
by the injection of 5-phosphatase.
5. Discussion
The present results show that, although InsP3 oscillations
probably arise in intact cells due to the stimulation of 3-kinase
activity by Ca2þ, these oscillations do not play a predominant
role neither in the triggering nor in the main characteristics of
Ca2þ oscillations. However, they do not exclude the possibil-
ity that InsP3 oscillations generated by another mechanism,
for example by a PKC-mediated feedback at the level of the
receptor-coupled G-protein, might play a crucial role for he-
patic Ca2þ oscillations [10]. Yet the observation [34] that In-
sP3-dependent cycles of Ca2þ release and re-uptake can be
reproduced in permeabilized hepatocytes with InsP3 clamped
at submaximal concentration, suggests that the Ca2þ feedback
on the InsP3 (InsP3R) might well be the central oscillatory
mechanism in this cell type. This suggestion is corroborated
in a more indirect manner by two other studies. The ¢rst one
shows that type 2 InsP3R, which is the most abundant in
hepatocytes [35], is required for the normal Ca2þ oscillations,
while types 1 and 3 do not sustain Ca2þ oscillations on their
own [36]. Although both type 1 and type 2 display a bell-
shaped dependence on Ca2þ, type 2 is known to be more
sensitive to cytosolic Ca2þ, which may explain its observed
predominant role in the generation of Ca2þ oscillations. The
other study also strongly suggests that the InsP3R is the driv-
ing force of Ca2þ oscillations: it shows that Ca2þ oscillations
(but not Ca2þ release) are abolished in DT40 cells in which
the sensitivity of the InsP3R to cytosolic Ca2þ has been de-
creased by substitution of the appropriate residues [37].
Nevertheless, even in the hypothesis of a primary role of the
InsP3R in the generation of Ca2þ oscillations, the origin of the
long periods observed in hepatocytes and other cells still re-
mains unsolved. The present study demonstrates that the clue
for these long periods can probably not be found in the Ca2þ
dependence of InsP3 catabolism, and thus emphasizes the ne-
cessity for investigating alternative mechanisms.
Acknowledgements: Supported by the Action de Recherche Concerte¤e
(CFB), the Belgium Programme of Interuniversity Poles of Attraction
(initiated by the Belgium State, Prime Minister’s O⁄ce) and a ‘Tour-
nesol’ program. G.D. is ‘Chercheur Quali¢e¤ du FNRS (Belgium)’. We
thank P. Champeil for his critical comments about the manuscript.
References
[1] Thomas, A.P., Bird, G.S., Hajnoczky, G., Robb-Gaspers, L.D.
and Putney Jr., J.W. (1996) FASEB J. 10, 1505^1517.
[2] Berridge, M.J., Lipp, P. and Bootman, M.D. (2000) Nat. Rev.
Mol. Cell Biol. 1, 11^21.
[3] Goldbeter, A., Dupont, G. and Berridge, M.J. (1990) Proc. Natl.
Acad. Sci. USA 87, 1461^1465.
[4] Sneyd, J., Keizer, J. and Sanderson, M.J. (1995) FASEB J. 9,
1463^1472.
[5] Hirose, K., Kadowaki, S., Tanabe, M., Takeshima, H. and Iino,
M. (1999) Science 284, 1527^1530.
[6] Nash, M.S., Young, K.W., Challiss, R.A. and Nahorski, S.R.
(2001) Nature 413, 381^382.
[7] Nash, M.S., Young, K.W., Willars, G.B., Challiss, R.A. and
Nahorski, S.R. (2001) Biochem. J. 356, 137^142.
[8] Berridge, M.J. (1987) Ann. N.Y. Acad. Sci. 494, 39^51.
[9] Woods, N.M., Cuthbertson, K.S. and Cobbold, P.H. (1987) Bio-
chem. J. 246, 619^623.
[10] Kummer, U., Olsen, L.F., Dixon, C.J., Green, A.K., Bornberg-
Bauer, E. and Baier, G. (2000) Biophys. J. 79, 1188^1195.
[11] Meyer, T. and Stryer, L. (1988) Proc. Natl. Acad. Sci. USA 85,
5051^5055.
[12] Harootunian, A.T., Kao, J.P., Paranjape, S. and Tsien, R.Y.
(1991) Science 251, 75^78.
[13] Renard, D., Poggioli, J., Berthon, B. and Claret, M. (1987) Bio-
chem. J. 243, 391^398.
[14] Bird, G.S. and Obie, J.F. (1997) Cell Calcium 21, 253^256.
[15] Shears, S.B. (1992) Adv. Second Messenger Phosphoprotein Res.
26, 63^92.
FEBS 26869 3-1-03
G. Dupont et al./FEBS Letters 534 (2003) 101^105104
[16] Takazawa, K., Vandekerckhove, J., Dumont, J.E. and Erneux,
C. (1990) Biochem. J. 272, 107^1112.
[17] Sims, C.E. and Allbritton, N.L. (1998) J. Biol. Chem. 273, 4052^
4058.
[18] Dupont, G. and Erneux, C. (1997) Cell Calcium 22, 321^331.
[19] Mishra, J. and Bhalla, S. (2002) Biophys. J. 83, 1298^1316.
[20] Chatton, J.-Y., Cao, Y. and Stucki, J. (1998) Biophys. J. 74, 523^
531.
[21] Fink, C., Slepchenko, B. and Loew, L. (1999) Biophys. J. 77,
617^628.
[22] Dupont, G. and Swillens, S. (1996) Biophys. J. 71, 1714^1722.
[23] Combettes, L., Tran, D., Tordjmann, T., Laurent, M., Berthon,
B. and Claret, M. (1994) Biochem. J. 304, 585^594.
[24] Tordjmann, T., Berthon, B., Claret, M. and Combettes, L. (1997)
EMBO J. 16, 5398^5407.
[25] De Smedt, F., Missiaen, L., Parys, J.B., Vanweyenberg, V., De
Smedt, H. and Erneux, C. (1997) J. Biol. Chem. 272, 17367^
17375.
[26] Spray, D.C., Bai, S., Burk, R.D. and Saez, J.C. (1994) Prog.
Liver Dis. 12, 1^18.
[27] Tordjmann, T., Clair, C., Claret, M. and Combettes, L. (2000)
in: Calcium: The Molecular Basis of Calcium Action in Biology
and Medicine (Pochet, R., Donato, R., Haiech, J., Heizmann, C.
and Gerke, V., Eds.), pp. 219^232, Kluwer Academic Publishers,
Dordrecht.
[28] Dupont, G., Tordjmann, T., Clair, C., Swillens, S., Claret, M.
and Combettes, L. (2000) FASEB J. 14, 279^289.
[29] Ho«fer, T. (1999) Biophys. J. 77, 1244^1256.
[30] Thomas, S., Brake, B., Luzio, J., Stanley, K. and Banting, G.
(1994) Biochim. Biophys. Acta 1220, 219^222.
[31] Biden, T., Altin, J., Karjalainen, A. and Bygrave, F. (1988) Bio-
chem. J. 256, 697^701.
[32] Conigrave, A., Patwardhan, A., Broomhead, L. and Roufogalis,
B. (1992) Cell Signal. 4, 303^321.
[33] Verjans, B., Moreau, C. and Erneux, C. (1994) Mol. Cell. Endo-
crinol. 98, 167^171.
[34] Hajnoczky, G. and Thomas, A.P. (1997) EMBO J. 16, 3533^
3543.
[35] Wojcikiewicz, R.J.H. (1995) J. Biol. Chem. 270, 11678^11683.
[36] Miyakawa, T., Maeda, A., Yamazawa, T., Hirose, K., Kurosaki,
T. and Iino, M. (1999) EMBO J. 18, 1303^1308.
[37] Miyakawa, T., Mizushima, A., Hirose, K., Yamazawa, T., Bez-
prozvanny, I., Kurosaki, T. and Iino, M. (2001) EMBO J. 20,
1674^1680.
FEBS 26869 3-1-03
G. Dupont et al./FEBS Letters 534 (2003) 101^105 105
